Product
FCR001
2 clinical trials
2 indications
Indication
Kidney TransplantIndication
Systemic SclerosisClinical trial
A Single-arm, Multi-center, Exploratory Safety and Efficacy Study of FCR001 Cell-based Therapy to Induce Donor-specific Tolerance in Previously Transplanted Recipients of a Kidney From a Living Donor, and Safety in FCR001 DonorsStatus: Withdrawn, Estimated PCD: 2023-02-28
Clinical trial
A Single-arm, Multi-center, Open-label Proof of Concept Safety and Efficacy Study of FCR001 Cell-based Therapy in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis at Risk for Organ FailureStatus: Withdrawn, Estimated PCD: 2026-11-01